AgeX Therapeutics Inc (AGE): Telomerase and cancer: A complex relatio...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	23
Posts	1789
Boards Moderated	0
Alias Born	12/05/2020

saxonia40271

Re: None

Sunday, 05/23/2021 5:03:00 PM

Sunday, May 23, 2021 5:03:00 PM

Telomerase and cancer: A complex relationship

http://www.lidsen.com/journals/geriatrics/geriatrics-05-01-156

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AGE News

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results • GlobeNewswire Inc. • 03/22/2024 09:27:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/07/2024 09:49:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:47:08 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/07/2024 12:47:43 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:01:43 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:21 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:05:20 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/05/2024 12:19:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:05:39 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/17/2024 09:19:13 PM
Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 01/16/2024 02:11:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:05:36 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/09/2024 09:16:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:05:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:02:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:25:54 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/13/2023 10:11:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:05:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:05:38 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/16/2023 09:01:20 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/15/2023 02:38:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:25:21 PM
AgeX Therapeutics Reports Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM

More AGE News

InvestorsHub NewsWire

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover